Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Adult |
Dose: Ophthalmic drops – One drop Frequency: twice daily approximately 12 hours apart Note: in the affected eye(s) |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: less than 2 years |
Dose: Not for use Note: Not for use in children below the age of 2 years |
|
Age: greater than 2 years |
Dose: Dosage not specified Note: Use with caution in children greater than 2 years of age |
Administration
- Wash hands before use
- Shake well before using
Side Effect
- Allergic conjunctivitis
- Conjunctival folliculosis
- Conjunctival hyperemia
- Eye pruritus
- Ocular burning
- Stinging
- Asthenia
- Blepharitis
- Corneal erosion
- Depression
- Epiphora
- Eye discharge
- Eye dryness
- Eye irritation
- Eye pain
- Eyelid edema
- Eyelid erythema
- Eyelid pruritus
- Foreign body sensation
- Headache
- Hypertension
- Oral dryness
- Somnolence
- Superficial punctate keratitis
- Visual disturbance
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
CNS depressants
|
Additive or potentiating effect (Brimonidine component)
|
|
β-blockers, Antihypertensive (Captopril, Enalapril, Lisinopril, Ramipril, Benazepril, Fosinopril, Quinapril, Perindopril, Losartan, Valsartan, Candesartan, Irbesartan, Telmisartan, Olmesartan, Propranolol, Metoprolol, Atenolol, Carvedilol, Bisoprolol, Nadolol, Amlodipine, Diltiazem, Verapamil, Nifedipine, Nicardipine, Hydrochlorothiazide, Chlorthalidone, Indapamide, Furosemide, Bumetanide, Torsemide, Spironolactone, Amiloride, Triamterene, Prazosin, Doxazosin, Terazosin, Clonidine, Methyldopa, Hydralazine, Minoxidil), cardiac glycosides
|
Caution required (Brimonidine component)
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store at a cool & dry place, protect from light. Do not use longer than 30 days after the first opening of the bottle. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.